The Patent Finder

Idera Pharmaceuticals, Inc.

5 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

1
Ending by 2030
Jul 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 4, 2027
    The maintenance fee for Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (US 9,096,858) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 5 terms have ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 5 of 5

PatentTitleStatus Expires Confidence
US 7,960,362Synthetic agonists of TLR9
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,877,722Compositions for inhibiting gene expression and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,987,221Potentiation of Autoimmune and Inflammatory Disease Treatments by Immune Regulatory Oligonucleotide (IRO) Antagonists of TLR7 and TLR9
In force
 · High confidence
In forceHigh confidence
US 9,096,858Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,470,674Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
In force
Term ended Nov 14, 2026 · From the USPTO record
In forceTerm ended Nov 14, 2026From the USPTO record
Also on record, not counted in the 5: 74 lapsed for an unpaid fee · 79 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

36 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited